Artificial Intelligence in the Management of Patients with Bronchial Asthma: Current Opportunities and Prospects (Review)
Tuberculosis, Lung Diseases, HIV Infection · 11.05.2026 · (2) · 64-70
DOI: 10.30978/tb2026-2-64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tuberculosis, Lung Diseases, HIV Infection, online erschienen am 11.05.2026. Verfasst von S.M. Andreychyn und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).
Abstract (Originalsprache)
Objective — to analyse and summarise current data on the use of artificial intelligence in the management of patients with bronchial asthma and prospects for development. Materials and methods. A search of the PubMed, Google Scholar and Web of Science databases was conducted. Results and discussion. AI-based technological solutions improve diagnostic accuracy and enable personalised monitoring of the health status of patients with asthma. Machine learning and deep learning algorithms integrate clinical, functional, laboratory and genetic data, contributing to more precise phenotyping and prediction of exacerbations. Models based on the analysis of respiratory sounds and spirometry demonstrate high accuracy and help automate the assessment of lung function. Prognostic machine-learning models effectively evaluate the risk of exacerbations and stratify patients by the probability of dyspnoea attacks. Mobile applications, smart inhalers and wearable sensors provide continuous monitoring of symptoms, treatment adherence and the influence of external factors. Chatbots and digital decision-support systems enhance patient—clinician communication, education and the provision of personalised recommendations. Genotype-based and complex models predict treatment response and the risk of exacerbations, contributing to the personalisation of bronchial asthma management. Conclusions. Artificial intelligence opens new possibilities for the management of patients with bronchial asthma, providing more accurate diagnosis, phenotyping and prediction of exacerbations. Machine learning and deep learning algorithms enable the analysis of large volumes of clinical, laboratory and functional data, contributing to the personalisation of therapy and risk stratification. The use of mobile applications, smart inhalers and wearable sensors ensures continuous monitoring of symptoms, treatment adherence and the influence of external factors, improving asthma control. Despite its high potential, the implementation of artificial intelligence in clinical practice for the management of bronchial asthma requires additional validation of models, methodological standardization, and integration into healthcare workflows.
Zitieren
APA
Andreychyn, S., Melnychaiko, I., & Hryshchuk, L. (2026). Artificial Intelligence in the Management of Patients with Bronchial Asthma: Current Opportunities and Prospects (Review). Tuberculosis, Lung Diseases, HIV Infection, 64-70. https://doi.org/10.30978/tb2026-2-64
Vancouver
Andreychyn S, Melnychaiko I, Hryshchuk L. Artificial Intelligence in the Management of Patients with Bronchial Asthma: Current Opportunities and Prospects (Review). Tuberculosis, Lung Diseases, HIV Infection. 2026:64-70. doi:10.30978/tb2026-2-64
BibTeX
@article{Andreychyn2026,
author = {Andreychyn, S.M. and Melnychaiko, I.Ya. and Hryshchuk, L.A.},
title = {Artificial Intelligence in the Management of Patients with Bronchial Asthma: Current Opportunities and Prospects (Review)},
journal = {Tuberculosis, Lung Diseases, HIV Infection},
year = {2026},
number = {2},
pages = {64--70},
doi = {10.30978/tb2026-2-64}
}
EUVIMED